|
⚲
|
| Keyboard |
| Ling Geoffrey MD
✚
|
|
|---|---|
| CIK # | 0001800097 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001800097] | |
| 4 | [0001800097] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Ling Geoffrey MD | |
| Celularity Inc | |
| GYRE Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Celularity Inc CELU
Class A Common Stock
|
2026-01-12 | Grant | 19,231 | $0.00 | |
|
Celularity Inc CELU
Stock Options · derivative
|
2025-12-29 | Grant | 156,250 | $0.00 | |
|
Celularity Inc CELU
Class A Common Stock
|
2025-12-29 | Grant | 125,000 | $0.00 | |
|
Celularity Inc CELU
Class A Common Stock
|
2025-12-19 | Grant | 67,416 | $0.00 | |
|
Celularity Inc CELU
Class A Common Stock
|
2025-11-19 | Grant | 44,379 | $0.00 | |
|
Celularity Inc CELU
Class A Common Stock
|
2024-12-19 | Grant | 67,416 | $0.00 | |
|
Celularity Inc CELU
Stock Option (Right to Buy) · derivative
|
2024-12-19 | Grant | 84,746 | $0.00 | |
|
Celularity Inc CELU
Stock Option Grant (Right to Buy) · derivative
|
2023-08-31 | Grant | 1,250,000 | $0.00 | |
|
GYRE Therapeutics Inc CBIO
Common Stock
|
2022-01-07 | Grant | 12,855 | $0.00 | |
|
GYRE Therapeutics Inc CBIO
Common Stock
|
2021-10-01 | Grant | 2,858 | $0.00 | |
|
GYRE Therapeutics Inc CBIO
Common Stock
|
2021-07-01 | Grant | 2,713 | $0.00 | |
|
GYRE Therapeutics Inc CBIO
Stock Option (Right to Buy) · derivative
|
2021-06-09 | Grant | 14,000 | $0.00 | |
|
GYRE Therapeutics Inc CBIO
Common Stock
|
2021-04-01 | Grant | 2,331 | $0.00 | |
|
GYRE Therapeutics Inc CBIO
Common Stock
|
2021-01-05 | Grant | 1,782 | $0.00 | |
|
GYRE Therapeutics Inc CBIO
Common Stock
|
2020-10-01 | Grant | 2,616 | $0.00 | |
|
GYRE Therapeutics Inc CBIO
Common Stock
|
2020-07-01 | Grant | 1,703 | $0.00 | |
|
GYRE Therapeutics Inc CBIO
Stock Option (Right to Buy) · derivative
|
2020-06-11 | Grant | 5,000 | $0.00 | |
|
GYRE Therapeutics Inc CBIO
Common Stock
|
2020-04-01 | Grant | 1,932 | $0.00 | |
|
GYRE Therapeutics Inc CBIO
Common Stock
|
2020-02-25 | Buy | 3,000 | $6.23 | 18,690 |
|
GYRE Therapeutics Inc CBIO
Stock Option (Right to Buy) · derivative
|
2020-01-15 | Grant | 10,000 | $0.00 |